NCT07909655
A Phase 2 Study of HB0056 in Patients With Idiopathic Pulmonary Fibrosis
StatusNot Yet Recruiting
PhasePhase 2
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Change from Baseline in FVC% (Percent of Predicted FVC value) to week 24
Timeframe: 24 weeks
Secondary (1)
Change from Baseline in FVC% (Percent of Predicted FVC value)
Arms and interventions
HB0056 group 1Experimental
HB0056 group 2Experimental
control groupPlacebo comparator
Drugs: HB0056, Placebo
Sites
2 sites in 1 country